Avicanna, Inc. (AVCN.TO)
0.23
0.00 (0.00%)
CAD |
TSX |
Jan 09, 15:59
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 27.10M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -32.84% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.009 |
| Price to Book Value | 8.712 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 97.07% |
Profile
| Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. It operates through the following two segments: Research and Development and Cultivation. The Research and Development segment conducts business in Johnson & Johnson Innovation centre. The Cultivation segment controls two companies located in Santa Marta, Colombia that are authorized to cultivate and process cannabis for the production of Extracts, including Cannabidiol and Tetrahydrocannabinol. The company was founded by Aras Azadian, Kyle Langstaff, and Setu Purohit in May 2015 and is headquartered in Toronto, Canada. |
| URL | http://www.avicanna.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. It operates through the following two segments: Research and Development and Cultivation. The Research and Development segment conducts business in Johnson & Johnson Innovation centre. The Cultivation segment controls two companies located in Santa Marta, Colombia that are authorized to cultivate and process cannabis for the production of Extracts, including Cannabidiol and Tetrahydrocannabinol. The company was founded by Aras Azadian, Kyle Langstaff, and Setu Purohit in May 2015 and is headquartered in Toronto, Canada. |
| URL | http://www.avicanna.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |